AngioDynamics Receives FDA Breakthrough Device Designation Fpr AngioVac System For Non-Surgical Removal of Right Heart Vegetation
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics has received FDA Breakthrough Device Designation for its AngioVac System, a non-surgical solution for the removal of right heart vegetation. This designation will expedite the development and review process of the device.
August 15, 2023 | 8:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AngioDynamics' AngioVac System has received FDA Breakthrough Device Designation, which will expedite its development and review process. This could potentially lead to increased revenues for the company in the future.
The FDA Breakthrough Device Designation is given to devices that provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases. This designation will expedite the development and review process of the AngioVac System, potentially leading to earlier market entry and increased revenues for AngioDynamics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100